FDA Approves New Pediatric Dosing for Zidovudine (Retrovir)
"On September 19, 2008, FDA approved a pediatric efficacy supplement for Retrovir syrup, capsules and tablets allowing for a twice daily dosing regimen in children 6 weeks to 18 years of age. It also provides for dosing by weight in addition to dosing by body surface area."
More information is available:
New Technology May Help Prevent HIV Transmission via Breastfeeding
"A new nipple shield capable of disinfecting breast milk as it passes through holds hope for preventing mother-to-baby HIV transmission, researchers say."
More information is available:
Study: Postpartum Discontinuation of ART May Result in Increased Risk of Adverse Outcomes
"Of 172 pregnancies, postpartum ART discontinuation occurred in 123 (71.5%) women... . Median follow-up was 32.5 months after delivery. There were 12 OIs and 2 deaths; 10 OIs and both deaths occurred in women who had discontinued ART. ... Postpartum ART discontinuation is common ... but may leave women at increased risk of long term adverse outcomes."
More information is available:
CDC Releases New Slide Set on HIV/AIDS Diagnoses among Men Who Have Sex with Men (MSM)
"This slide set conveys important information on new and prevalent HIV and AIDS diagnoses among MSM in the United States."
|
